8-K//Current report
PhaseBio Pharmaceuticals Inc 8-K
Accession 0001169245-23-000052
CIK 0001169245operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:17 AM ET
Size
158.3 KB
Accession
0001169245-23-000052
Documents
- 8-Kphas-20230927.htmPrimary
8-K
- EX-101.SCHphas-20230927.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABphas-20230927_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREphas-20230927_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLphas-20230927_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001169245-23-000052-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001169245
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 7:17 AM ET
- Size
- 158.3 KB